We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

266 hedge funds and large institutions have $4.24B invested in Immunogen Inc in 2023 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

426% more capital invested

Capital invested by funds: $805M → $4.24B (+$3.43B)

304% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 25

93% more call options, than puts

Call options by funds: $69.3M | Put options by funds: $35.8M

40% more funds holding

Funds holding: 190 → 266 (+76)

7% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 72

Holders
266
Holders Change
+76
Holders Change %
+40%
% of All Funds
4.18%
Holding in Top 10
13
Holding in Top 10 Change
+13
Holding in Top 10 Change %
% of All Funds
0.2%
New
101
Increased
67
Reduced
72
Closed
25
Calls
$69.3M
Puts
$35.8M
Net Calls
+$33.4M
Net Calls Change
+$21.4M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$114M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$103M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$74.2M
4
FFM
Fairmount Funds Management
Pennsylvania
+$71.2M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$70M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$231M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$201M
3
State Street
State Street
Massachusetts
-$108M
4
MC
Maverick Capital
Texas
-$48M
5
Morgan Stanley
Morgan Stanley
New York
-$47M
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
101
BIT Capital
Germany
$3.93M +$2.08M +176,325 +549%
MAP
102
Moody Aldrich Partners
Massachusetts
$3.87M +$2.42M +204,856 New
Citigroup
103
Citigroup
New York
$3.67M -$10.7M -904,970 -82%
IIM
104
Ironwood Investment Management
Massachusetts
$3.66M +$3.86K +327 +0.2%
EI
105
EAM Investors
California
$3.63M +$2.27M +192,519 New
SEI Investments
106
SEI Investments
Pennsylvania
$3.63M +$1.74M +147,318 +326%
BC
107
Birchview Capital
Vermont
$3.59M +$472K +40,000 +27%
VCIM
108
Velan Capital Investment Management
Georgia
$3.58M +$2.24M +189,500 New
KA
109
Kercheville Advisors
Texas
$3.32M -$903K -76,512 -30%
State of New Jersey Common Pension Fund D
110
State of New Jersey Common Pension Fund D
New Jersey
$3.31M +$2.07M +175,647 New
Norges Bank
111
Norges Bank
Norway
$3.11M +$1.95M +165,000 New
CSS
112
Cubist Systematic Strategies
Connecticut
$3.11M +$1.81M +153,339 +1,341%
ACH
113
ArrowMark Colorado Holdings
Colorado
$3.1M +$1.94M +164,492 New
Manulife (Manufacturers Life Insurance)
114
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.05M +$925K +78,310 +94%
Alyeska Investment Group
115
Alyeska Investment Group
Illinois
$2.83M +$1.77M +150,000 New
UBS Group
116
UBS Group
Switzerland
$2.57M -$4.84M -410,171 -75%
FIM
117
Fernwood Investment Management
Massachusetts
$2.43M -$207K -17,500 -12%
MIM
118
MetLife Investment Management
New Jersey
$2.41M +$206K +17,450 +16%
Mirae Asset Global Investments
119
Mirae Asset Global Investments
South Korea
$2.3M -$279K -23,651 -16%
Victory Capital Management
120
Victory Capital Management
Texas
$2.29M +$1.14M +96,353 +384%
AIG
121
American International Group
New York
$2.2M +$156K +13,198 +13%
RSCM
122
Rock Springs Capital Management
Maryland
$2.13M +$1.33M +112,620 New
CM
123
Capula Management
Cayman Islands
$2.1M +$1.31M +111,320 New
Walleye Capital
124
Walleye Capital
New York
$2.04M +$1.28M +108,000 New
GTC
125
Ghost Tree Capital
New York
$1.89M -$295K -24,977 -20%
3 4
5
6 7

IMGN Hedge Fund Activity: Q2 2023 in Review

266 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2023, worth a combined $4.24B — up 426% from $805M a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new IMGN positions and 25 closed out — a net gain of 76 holders — while 67 added to existing stakes and 72 trimmed.

The largest buyer was Redmile Group, adding an estimated $114M. The largest seller was RA Capital Management, cutting an estimated $231M.

  • 266 institutional investors held Immunogen Inc (IMGN) as of Q2 2023, up from 190 in Q1 2023.
  • Funds reported $4.24B of Immunogen Inc stock for Q2 2023, up 426% quarter-over-quarter.
  • 101 funds opened new Immunogen Inc positions in Q2 2023 and 25 closed out, a net change of +76 holders.
  • The largest Immunogen Inc buyer in Q2 2023 was Redmile Group, an estimated $114M added.
  • The largest Immunogen Inc seller in Q2 2023 was RA Capital Management, an estimated $231M sold.

Based on aggregated 13F filings for Q2 2023.